Optimal long-term pharmacological treatment of patients with venous thromboembolism that was unprovoked or associated with weak risk factors
G Palareti - Expert Review of Hematology, 2017 - Taylor & Francis
Introduction: Unprovoked venous thromboembolism (VTE) tend to recur. Many factors,
patient-or event-related, influence the individual risk of recurrence. After initial and long-term …
patient-or event-related, influence the individual risk of recurrence. After initial and long-term …
Optimal long-term pharmacological treatment of patients with venous thromboembolism that was unprovoked or associated with weak risk factors
G Palareti - Expert review of hematology, 2017 - pubmed.ncbi.nlm.nih.gov
Unprovoked venous thromboembolism (VTE) tend to recur. Many factors, patient-or event-
related, influence the individual risk of recurrence. After initial and long-term (usually for 3-6 …
related, influence the individual risk of recurrence. After initial and long-term (usually for 3-6 …
Optimal long-term pharmacological treatment of patients with venous thromboembolism that was unprovoked or associated with weak risk factors.
G Palareti - Expert Review of Hematology, 2017 - europepmc.org
Unprovoked venous thromboembolism (VTE) tend to recur. Many factors, patient-or event-
related, influence the individual risk of recurrence. After initial and long-term (usually for 3-6 …
related, influence the individual risk of recurrence. After initial and long-term (usually for 3-6 …